plete trial -) $6M + advance E-CEL chemo/rad recovery to 2nd IND + in-license gene therapy vector (e.g., sickle cell) $8nn et99FITIc + complete 2nd IND (cancer chemo/rad treatment recovery program) & apply for 2nd $5M CIRM grant + initiate pre-clinical gene therapy studies EFTA00292536 Anticipat